Skip to main content

Study

Dietary Supplement Myoinositol May Help Thyroid Health in Seniors

Myoinositol, combined with selenium, showed potential for improving thyroid function and reducing autoimmune thyroid disease markers.

Thyroid HealthHealthy AgingSupplement
Study Credibility: Low2.8/10Early findingsNot enough evidence yetTalk with your clinician
PublishedJan 2022Last reviewedMay 2026
Email this

Summary

In plain language

Recent research explores the benefits of a dietary supplement called Myoinositol, combined with selenium, for thyroid health. This study found that taking Myoinositol alongside selenium could lower the levels of thyroid-stimulating hormone (TSH) and reduce thyroid antibodies, which are often high in conditions like Hashimoto’s thyroiditis, a common thyroid disorder. These findings suggest that this combination might support better thyroid function and potentially ease symptoms for seniors with autoimmune thyroid issues. If you have thyroid concerns, this study provides an option to discuss with your healthcare provider.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study reviewed the effects of Myoinositol and selenium supplements on thyroid health, focusing on autoimmune thyroid diseases common in seniors. Researchers conducted multiple studies involving patients with subclinical hypothyroidism and autoimmune thyroiditis, finding notable reductions in TSH levels and thyroid antibodies.

  • The study used controlled trials where participants were given Myoinositol and selenium supplements over six months.

  • Key findings included a 31% drop in TSH and a reduction in thyroid antibodies, suggesting improved thyroid function.

  • While promising, the study was supported by a single sponsor and further research is needed to fully understand the implications.

Before starting any new supplement, it’s wise to discuss potential benefits and risks with your healthcare provider.

Research Quality Score

Scored May 10, 2026 using rubric v9_2026-04-08.

Assessment

The study is a narrative review of existing literature on myoinositol and thyroid health, lacking original empirical data or rigorous methodological controls. It provides a broad overview but does not offer new statistical analysis or controlled study results. The relevance to seniors is moderate, as it discusses thyroid health generally without a specific focus on older adults.

Category Breakdown

CategoryScoreRating
Study design3.3/10
Bias control0.0/10
Statistical methods0.0/10
Reporting completeness5.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population5.0/10
Journal Reliability5.0/10

Additional Notes

The study's narrative review format limits its empirical rigor and applicability for direct clinical recommendations.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.